Cargando…

miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia

[Image: see text] MicroRNA miR-486-5p has been reported as a potential biomarker for diagnosis, prognosis, and as a therapeutic target in various cancers. In this study, we analyzed alterations in the expression of miR-486-5p in chronic Myeloid Leukemia (CML) patients. Initially, the expression of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ninawe, Anupama, Guru, Sameer Ahmad, Yadav, Prasant, Masroor, Mirza, Samadhiya, Amit, Bhutani, Namrata, Gupta, Naresh, Gupta, Richa, Saxena, Alpana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992144/ https://www.ncbi.nlm.nih.gov/pubmed/33778281 http://dx.doi.org/10.1021/acsomega.1c00035

Ejemplares similares

Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients
por: Mir, Rashid, et al.
Publicado: (2015)

microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients
por: Beg Mirza, Masroor Ali, et al.
Publicado: (2019)

Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
por: Guru, Sameer Ahmad, et al.
Publicado: (2022)

Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
por: Guru, Sameer Ahmad, et al.
Publicado: (2022)

Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia
por: Bhattacharya, Jenna B, et al.
Publicado: (2017)

Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer
por: Yadav, Prasant, et al.
Publicado: (2018)

Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients
por: Beg, Mirza Masroor Ali, et al.
Publicado: (2019)

Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
por: Mir, Rashid, et al.
Publicado: (2016)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
por: Jiang, Jingwei, et al.
Publicado: (2018)

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
por: de Lima, Marcos, et al.
Publicado: (2018)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Extended dosing with CC‐486 (oral azacitidine) in patients with myeloid malignancies
por: Savona, Michael R., et al.
Publicado: (2018)

miR-486 is modulated by stretch and increases ventricular growth
por: Lange, Stephan, et al.
Publicado: (2019)

Pediatric Chronic Myeloid Leukemia Presenting in a Mixed Phenotypic Blast Crisis: A Rare Occurrence
por: Bhattacharya, Jenna, et al.
Publicado: (2019)

Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
por: Dange, Prasad, et al.
Publicado: (2021)

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
por: Roboz, Gail J, et al.
Publicado: (2016)

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma
por: Tomioka, Yuya, et al.
Publicado: (2023)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
por: Gupta, Monika, et al.
Publicado: (2015)

Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction
por: Zhang, Rui, et al.
Publicado: (2015)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2017)

miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome
por: Samani, Adrienne, et al.
Publicado: (2022)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023)

Down-regulation of miR-486-5p expression inhibits the proliferation and invasion of human extravillous trophoblasts, and decreased peripheral plasma miR-486-5p level is associated with human early pregnancy loss: Role of miR-486-5p in human early pregnancy loss
por: Gu, Yan, et al.
Publicado: (2023)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

MiR-486 Regulates Lactation and Targets the PTEN Gene in Cow Mammary Glands
por: Li, Dan, et al.
Publicado: (2015)

Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma
por: Chen, Hui, et al.
Publicado: (2015)

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis
por: Borzi, Cristina, et al.
Publicado: (2017)

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)

Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
por: Marwah, Nisha, et al.
Publicado: (2019)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
por: Chandra, Abhilash, et al.
Publicado: (2020)

Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro
por: Biswas, Biplob Kumar, et al.
Publicado: (2020)

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
por: Amaya, Maria, et al.
Publicado: (2023)

MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2017)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells
por: Hershkovitz Rokah, Oshrat, et al.
Publicado: (2012)

miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2017)

The role of TLR8 signaling in Acute Myeloid Leukemia Differentiation
por: Ignatz-Hoover, James J, et al.
Publicado: (2014)

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
por: Aoi, Wataru, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2d5vaibhdbgsp87fc0lfe0mtfm